Education
About Us
Working with TipRanks
Follow Us
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
Earnings Data
Report Date
Mar 26, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.42Last Year’s EPS
0.41Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call displayed strong revenue growth and strategic steps towards expanding market presence through the acquisition and alliance models. However, increased operational costs and net loss pose challenges. Despite these hurdles, the company is optimistic about its new business model and future revenue potential.Company Guidance
Significant Revenue Growth
For the third quarter of 2025, revenue increased 76% to $6.8 million compared to $3.9 million in Q3 2024 and 78% sequentially versus second quarter of 2025.
Impact of SCN Acquisition
The acquisition of the Sleep Center of Nevada (SCN) contributed significantly to revenue, with a $2.2 million increase in OSA sleep testing services and $1.3 million from new treatment centers.
New Business Model Success
The pivot to a new business model focusing on sleep medical practice acquisition is showing positive results, with the strategic move set to enhance performance in coming quarters.
High Demand for Vivos Treatment
Approximately two-thirds of SCN patients opt for Vivos treatment over alternatives, with an average case value of over $5,000.
VVOS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VVOS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 19, 2025 | $2.36 | $2.12 | -10.17% |
Aug 19, 2025 | $4.27 | $4.13 | -3.28% |
May 15, 2025 | $3.06 | $2.54 | -16.99% |
Mar 31, 2025 | $2.85 | $2.63 | -7.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vivos Therapeutics (VVOS) report earnings?
Vivos Therapeutics (VVOS) is schdueled to report earning on Mar 26, 2026, After Close (Confirmed).
What is Vivos Therapeutics (VVOS) earnings time?
Vivos Therapeutics (VVOS) earnings time is at Mar 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VVOS EPS forecast?
VVOS EPS forecast for the fiscal quarter 2025 (Q4) is -0.42.